Author

Yosef Koronyo

Cedars-Sinai Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 4 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Assay:proteomics· 4 Approach:statistical model· 4 Research Focus:differential expression· 3 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Altan RentsendorjiD· 5 shared Dieu-Trang S. Fuchs· 5 shared Keith L. BlackiD· 5 shared Maya Koronyo‐HamaouiiD· 5 shared Alexander V. LjubimoviD· 4 shared Bhakta Prasad GaireiD· 4 shared Debra HawesiD· 4 shared Edward Robinson· 4 shared

Activity by Year

2024-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersNeuroscience

Altan RentsendorjORCID

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Sex-specific retina-brain signatures link ERα/ERβ imbalance with gliosis in Alzheimer's disease

Saba Shahin, Jean‐Philippe Vit, Altan Rentsendorj, Dieu-Trang S. Fuchs, Natalie Swerdlow, Bhakta Prasad Gaire, Edward Robinson, Anna Kissel, Larkin Hagerman, Ayzhah Williams, Alexander V. Ljubimov, Debra Hawes, Lon S. S. Schneider, Mehdi Mirzaei, Keith L Black, , Maya Koronyo‐Hamaoui

The paper identifies sex-specific molecular and pathological differences in the retina-brain axis of Alzheimer's disease, linking estrogen receptor imbalance to female vulnerability.

bioRxiv · May 5, 2026 · PreprintNeuroscience

Synergistic retinal UCHL1 dysregulation and synaptic vulnerability reflect Alzheimer's disease severity

Altan Rentsendorj, Jean‐Philippe Vit, A. Hutton, Yosef Koronyo, Saba Shahin, Edward Robinson, Ernesto Barrón, Anthony Rodriguez, Bhakta Prasad Gaire, Ousman Jallow, Julia Sheyn, Miyah R. Davis, Alexander V. Ljubimov, Stuart L. Graham, Vivek K. Gupta, , Maya Koronyo‐Hamaoui

The paper identifies UCHL1 dysregulation and synaptic loss in the retina as markers of Alzheimer's disease severity using integrated multi-omics analysis.

bioRxiv · Feb 5, 2026 · PreprintNeuroscience

Identification of Chlamydia pneumoniae and NLRP3 inflammasome activation in Alzheimer's disease retina

Bhakta Prasad Gaire, Yosef Koronyo, Jean‐Philippe Vit, A. Hutton, Lalita Subedi, Dieu-Trang S. Fuchs, Natalie Swerdlow, Altan Rentsendorj, Saba Shahin, Daisy Martinon, Edward Robinson, Alexander V. Ljubimov, Julie A. Schneider, Lon S. Schneider, Debra Hawes, , Maya Koronyo‐Hamaoui

The paper identifies Chlamydia pneumoniae infection and NLRP3 inflammasome activation in Alzheimer's disease retinas, linking them to disease progression and cognitive impairment.

Nature Communications · Jan 22, 2026Peer-reviewedNeuroscience

Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer's disease

Miyah R. Davis, Edward Robinson, Yosef Koronyo, Elena Salobrar‐García, Altan Rentsendorj, Bhakta Prasad Gaire, Nazanin Mirzaei, Rakez Kayed, Alfredo A. Sadun, Alexander V. Ljubimov, Lon S. S. Schneider, Debra Hawes, Keith L. Black, Dieu-Trang S. Fuchs, Maya Koronyo‐Hamaoui

This study shows that pathological tau isoforms in retinal ganglion cells (RGCs) are linked to RGC degeneration in Alzheimer's disease, with significant correlations between tau levels and disease severity.

Acta Neuropathologica Communications · Feb 15, 2025Peer-reviewedPathology

Epigenetic derepression of H3K9me3 mitigates Alzheimer-related pathology and improves cognition via immunomodulation and Vgf induction

Dieu-Trang S. Fuchs, Jean‐Philippe Vit, Altan Rentsendorj, Julia Sheyn, Haoshen Shi, Yosef Koronyo, Oksana M. Chepurna, Miyah R. Davis, Jered W. Wilson, Lon S. S. Schneider, Stuart L. Graham, Vivek Gupta, Margaret L. Fahnestock, Tao Sun, Michael T. Kleinman, , Maya Koronyo‐Hamaoui

This study shows that inhibiting H3K9me3 with ETP69 reduces AD pathology and improves cognition by modulating neuroinflammation and inducing Vgf.

bioRxiv · Oct 15, 2024 · PreprintNeuroscience